{"id":13395,"date":"2022-03-08T10:45:56","date_gmt":"2022-03-08T10:45:56","guid":{"rendered":"https:\/\/jurmed.ro\/medici\/?p=13395"},"modified":"2022-03-08T10:46:54","modified_gmt":"2022-03-08T10:46:54","slug":"femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament","status":"publish","type":"post","link":"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/","title":{"rendered":"Femeile din Romania care sufera de o forma agresiva de cancer de san au de acum un nou tratament"},"content":{"rendered":"<p style=\"text-align: justify\">Un medicament inovator pe baza de imunoterapie este acum disponibil pentru tratamentul pacientelor care sufera de o forma agresiva de cancer de san \u2013 cancerul de san triplu negativ. Tratamentul, dezvoltat de compania Roche, se adreseaza pacientelor cu cancer de san triplu negativ metastatic ale caror tumori prezinta o expresie a PD-L1 pozitiva<a href=\"#_ftn1\" name=\"_ftnref1\">[1]<\/a> \u015fi este disponibil gratuit pacientelor prin Programul Na\u0163ional de Oncologie.<\/p>\n<p style=\"text-align: justify\">Cancerul de san triplu negativ reprezinta aproximativ 15% din toate cazurile de cancer de san \u015fi este mai intalnit in randul femeilor cu varsta de pana in 50 de ani. La pacientele care sufera de forma metastatica, boala progreseaza rapid, iar sansele de supravietuire sunt mai mici la cinci ani de la diagnostic decat la alte subtipuri de cancer de san<a href=\"#_ftn2\" name=\"_ftnref2\">[2]<\/a>.<\/p>\n<p style=\"text-align: justify\">Numele acestui tip de cancer provine de la faptul ca la examenul histopatologic al tumorilor lipsesc trei tipuri de receptori, care altfel sunt identificati in majoritatea cazurilor de cancer de san; este vorba de receptorii pentru estrogen, progesteron \u015fi factorul uman de cre\u015ftere epidermala (HER-2).<a href=\"#_ftn3\" name=\"_ftnref3\">[3]<\/a>. Din cauza acestor caracteristici, cancerul de san triplu negativ nu raspunde la tratamentele pe baza de hormoni sau la terapiile care \u0163intesc receptorii HER-2.<\/p>\n<p style=\"text-align: justify\">\u201e<em>Tratamentul cancerului de san triplu negativ reprezinta o mare nevoie neacoperita in arsenalul terapeutic al oncologiei. Pana in prezent, tratamentul specific pentru acest tip de cancer de san era limitat la interven\u0163ia chirurgicala \u015fi\/sau chimioterapie\/radioterapie. Introducerea acestor tratamente noi pe baza de imunoterapie pot influen\u0163a pozitiv rezultatele tratamentului \u015fi cre\u015fte supravie\u0163uirea pe termen lung a pacientelor, precum \u015fi calitatea vie\u0163ii acestora.\u201d,<\/em> a declarat prof. dr. Serban Negru, medic primar oncolog, pre\u015fedintele Asocia\u0163iei OncoHelp.<\/p>\n<p style=\"text-align: justify\">Imunoterapia functioneaza prin intarirea sistemului imunitar care poate astfel sa combata eficient cancerul. Aceste tratamente aduc solutii terapeutice pentru pacienti cu tipuri de cancer cu o rata a supravietuirii redusa sau fara alternativa terapeutica.<\/p>\n<p style=\"text-align: justify\">\u201e<em>Ne bucuram ca pacientele care sufera de aceasta forma agresiva de cancer pot beneficia de acum inainte de un tratament specific bazat pe imunoterapie. Am vazut cu speran\u0163a ca noul Plan Na\u0163ional de Combatere a Cancerului are printre obiective accelerarea introducerii terapiilor inovatoare. Speram ca acest obiectiv sa ramana prioritar, pentru a oferi in sfar\u015fit pacien\u0163ilor din Romania tratamente la standarde similare cu alte \u0163ari dezvoltate<\/em>\u201d, a completat Cezar Irimia, pre\u015fedintele Federa\u0163iei Asocia\u0163iilor Bolnavilor de Cancer (FABC).<\/p>\n<p style=\"text-align: justify\">Cancerul de san este cel mai frecvent tip de cancer la femei, cu peste 2 milioane de cazuri noi in fiecare an<a href=\"#_ftn4\" name=\"_ftnref4\">[4]<\/a>. In anul 2020, in Romania, au fost peste 12.000 cazuri noi diagnosticate de cancer de san si aproape 4.000 decese ca urmare a acestei afectiuni.<a href=\"#_ftn5\" name=\"_ftnref5\">[5]<\/a> In acela\u015fi timp, rata de supravietuire la 5 ani a pacientelor cu cancer de san este de aproximativ 75% in Romania fata de 83% in Uniunea Europeana.<a href=\"#_ftn6\" name=\"_ftnref6\">[6]<\/a><\/p>\n<p style=\"text-align: justify\"><strong>Despre cancerul de san triplu negativ<a href=\"#_ftn7\" name=\"_ftnref7\">[7]<\/a><\/strong><\/p>\n<p style=\"text-align: justify\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Are \u015fanse mai mari de a metastaza \u015fi recidiva in urma tratamentelor folosite pana acum.<\/p>\n<p style=\"text-align: justify\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Este considerat o forma mai agresiva \u015fi cu o speran\u0163a de via\u0163a redusa, in principal din cauza lipsei tratamentelor \u0163intite pentru acest tip de cancer.<\/p>\n<p style=\"text-align: justify\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Apare mai des la femei cu varsta de pana in 50 de ani. Alte subtipuri de cancer de san sunt mai intalnite la persoane de peste 60 de ani.<\/p>\n<h4 style=\"text-align: justify\">***<\/h4>\n<p style=\"text-align: justify\"><strong>Despre Roche<\/strong><\/p>\n<p style=\"text-align: justify\">Roche este unul din pionerii globali ai industriei farmaceutice si de diagnostic, ce inoveaza continuu cu scopul de a imbunatati viata oamenilor. Sinergia dintre diviziile de Farmaceutice \u015fi Diagnostic au transformat Roche in lider global al medicinii personalizate, o strategie care isi propune sa ofere tratamentul potrivit pentru pacientul potrivit, in cele mai bune conditii posibile.<\/p>\n<p style=\"text-align: justify\">Roche este cea mai mare companie de biotehnologie la nivel mondial, ce ofera medicamente diferentiate clinic in domeniul oncologiei, imunologiei, bolilor infec\u0163ioase, oftalmologiei si afectiunilor sistemului nervos central. Roche este, de asemenea, lider mondial in diagnosticul in vitro \u015fi in diagnosticul histologic al cancerului, precum \u015fi pionier in managementul diabetului. Compania Genentech, din Statele Unite, este de\u0163inuta in totalitate de grupul Roche. De asemenea, Roche este ac\u0163ionarul majoritar al companiei Chugai Pharmaceutical din Japonia.<\/p>\n<p style=\"text-align: justify\">Prezent pe piata romaneasca inca din perioada interbelica, Roche isi redeschide reprezentanta locala in anul 1992.\u00a0 In anul 2005, grupul Roche ia decizia sa infiinteze societatea comerciala S.C. Roche Romania SRL, urmand ca activitatea reprezentantei din Bucuresti sa fie preluata de compania locala nou infiintata.<\/p>\n<p style=\"text-align: justify\">Roche ofera produse si servicii care acopera intreg spectrul ingrijirilor de sanatate, pornind de la preventie, tratament si pana la monitorizarea post-tratament, in arii terapeutice majore unde exista nevoi medicale neacoperite inca. Prin intermediul Roche Romania, ambele divizii ale Grupului Roche &#8211; divizia de farmaceutice si divizia de diagnostice &#8211; sunt prezente pe piata din tara noastra, oferind produse si servicii de inalta specializare. Pentru orice informatii suplimentare, va rugam sa accesati <a href=\"http:\/\/www.roche.ro\">www.roche.ro<\/a><\/p>\n<p style=\"text-align: justify\">Departamentul de Comunicare al Roche Romania: <a href=\"mailto:andrei.vlad@roche.com\">andrei.vlad@roche.com<\/a>, 0728292664<\/p>\n<p style=\"text-align: justify\"><a href=\"#_ftnref1\" name=\"_ftn1\">[1]<\/a> Celulele tumorale pot evada raspunsul imun al corpului prin exprimarea unei proteine \u200b\u200bnumite PD-L1. Unele imunoterapii blocheaza aceasta proteina pentru a cre\u015fte raspunsul sistemului imunitar impotriva tumorii.<\/p>\n<p style=\"text-align: justify\"><a href=\"#_ftnref2\" name=\"_ftn2\">[2]<\/a> Li X et al. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer. 2016;161(2):279-287.<\/p>\n<p style=\"text-align: justify\"><a href=\"#_ftnref3\" name=\"_ftn3\">[3]<\/a> Pal SK et al. Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat. 2011;125(3):627\u2013636.<\/p>\n<p style=\"text-align: justify\"><a href=\"#_ftnref4\" name=\"_ftn4\">[4]<\/a> Globocan 2020 \u2013 Breast Cancer Factsheet, disponibil la: <a href=\"https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/20-Breast-fact-sheet.pdf\">https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/20-Breast-fact-sheet.pdf<\/a><\/p>\n<p style=\"text-align: justify\"><a href=\"#_ftnref5\" name=\"_ftn5\">[5]<\/a> Globocan 2020 \u2013 Romanian factsheet, disponibil la: <a href=\"https:\/\/gco.iarc.fr\/today\/data\/factsheets\/populations\/642-romania-fact-sheets.pdf\">https:\/\/gco.iarc.fr\/today\/data\/factsheets\/populations\/642-romania-fact-sheets.pdf<\/a><\/p>\n<p style=\"text-align: justify\"><a href=\"#_ftnref6\" name=\"_ftn6\">[6]<\/a> Planul National de Combatere a Cancerului, <a href=\"http:\/\/www.ms.ro\/plan-national-de-combatere-a-cancerului-2\/\">http:\/\/www.ms.ro\/plan-national-de-combatere-a-cancerului-2\/<\/a><\/p>\n<p style=\"text-align: justify\"><a href=\"#_ftnref7\" name=\"_ftn7\">[7]<\/a> BreastCancer.org. Triple Negative Breast Cancer <a href=\"https:\/\/www.breastcancer.org\/symptoms\/types\/triple-negative\">https:\/\/www.breastcancer.org\/symptoms\/types\/triple-negative<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un medicament inovator pe baza de imunoterapie este acum disponibil pentru tratamentul pacientelor care sufera de o forma agresiva de cancer de san \u2013 cancerul de san triplu negativ. Tratamentul, [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":7607,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[176,984,983,985],"class_list":["post-13395","post","type-post","status-publish","format-standard","has-post-thumbnail","category-stiri-noutati","tag-cancer-de-san","tag-cancerul-de-san-triplu-negativ","tag-oncohelp","tag-roche-romani"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Femeile din Romania care sufera de o forma agresiva de cancer de san au de acum un nou tratament - Jurmed - Medici<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Femeile din Romania care sufera de o forma agresiva de cancer de san au de acum un nou tratament - Jurmed - Medici\" \/>\n<meta property=\"og:description\" content=\"Un medicament inovator pe baza de imunoterapie este acum disponibil pentru tratamentul pacientelor care sufera de o forma agresiva de cancer de san \u2013 cancerul de san triplu negativ. Tratamentul, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/\" \/>\n<meta property=\"og:site_name\" content=\"Jurmed - Medici\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-08T10:45:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-08T10:46:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/01\/Roche-Logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"480\" \/>\n\t<meta property=\"og:image:height\" content=\"283\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"costelv\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"costelv\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/\"},\"author\":{\"name\":\"costelv\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/d32bd0fe3243bb12082045e5e5635d2d\"},\"headline\":\"Femeile din Romania care sufera de o forma agresiva de cancer de san au de acum un nou tratament\",\"datePublished\":\"2022-03-08T10:45:56+00:00\",\"dateModified\":\"2022-03-08T10:46:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/\"},\"wordCount\":935,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/01\/Roche-Logo.jpg\",\"keywords\":[\"cancer de san\",\"cancerul de san triplu negativ\",\"OncoHelp\",\"Roche Romani\"],\"articleSection\":[\"Stiri \/ Noutati\"],\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/\",\"url\":\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/\",\"name\":\"Femeile din Romania care sufera de o forma agresiva de cancer de san au de acum un nou tratament - Jurmed - Medici\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/01\/Roche-Logo.jpg\",\"datePublished\":\"2022-03-08T10:45:56+00:00\",\"dateModified\":\"2022-03-08T10:46:54+00:00\",\"author\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/d32bd0fe3243bb12082045e5e5635d2d\"},\"breadcrumb\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#primaryimage\",\"url\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/01\/Roche-Logo.jpg\",\"contentUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/01\/Roche-Logo.jpg\",\"width\":480,\"height\":283,\"caption\":\"Atrofia\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/jurmed.ro\/medici\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Femeile din Romania care sufera de o forma agresiva de cancer de san au de acum un nou tratament\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#website\",\"url\":\"https:\/\/jurmed.ro\/medici\/\",\"name\":\"Jurmed - Medici\",\"description\":\"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/jurmed.ro\/medici\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/d32bd0fe3243bb12082045e5e5635d2d\",\"name\":\"costelv\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/562bbd538aef9094eff6466c34ed9504fe82c1cb144e421d853e80c3b3d5a9f8?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/562bbd538aef9094eff6466c34ed9504fe82c1cb144e421d853e80c3b3d5a9f8?s=96&r=g\",\"caption\":\"costelv\"},\"url\":\"https:\/\/jurmed.ro\/medici\/author\/costelvoicu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Femeile din Romania care sufera de o forma agresiva de cancer de san au de acum un nou tratament - Jurmed - Medici","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/","og_locale":"ro_RO","og_type":"article","og_title":"Femeile din Romania care sufera de o forma agresiva de cancer de san au de acum un nou tratament - Jurmed - Medici","og_description":"Un medicament inovator pe baza de imunoterapie este acum disponibil pentru tratamentul pacientelor care sufera de o forma agresiva de cancer de san \u2013 cancerul de san triplu negativ. Tratamentul, [&hellip;]","og_url":"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/","og_site_name":"Jurmed - Medici","article_published_time":"2022-03-08T10:45:56+00:00","article_modified_time":"2022-03-08T10:46:54+00:00","og_image":[{"width":480,"height":283,"url":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/01\/Roche-Logo.jpg","type":"image\/jpeg"}],"author":"costelv","twitter_misc":{"Scris de":"costelv","Timp estimat pentru citire":"4 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#article","isPartOf":{"@id":"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/"},"author":{"name":"costelv","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/d32bd0fe3243bb12082045e5e5635d2d"},"headline":"Femeile din Romania care sufera de o forma agresiva de cancer de san au de acum un nou tratament","datePublished":"2022-03-08T10:45:56+00:00","dateModified":"2022-03-08T10:46:54+00:00","mainEntityOfPage":{"@id":"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/"},"wordCount":935,"commentCount":0,"image":{"@id":"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/01\/Roche-Logo.jpg","keywords":["cancer de san","cancerul de san triplu negativ","OncoHelp","Roche Romani"],"articleSection":["Stiri \/ Noutati"],"inLanguage":"ro-RO","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/","url":"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/","name":"Femeile din Romania care sufera de o forma agresiva de cancer de san au de acum un nou tratament - Jurmed - Medici","isPartOf":{"@id":"https:\/\/jurmed.ro\/medici\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#primaryimage"},"image":{"@id":"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/01\/Roche-Logo.jpg","datePublished":"2022-03-08T10:45:56+00:00","dateModified":"2022-03-08T10:46:54+00:00","author":{"@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/d32bd0fe3243bb12082045e5e5635d2d"},"breadcrumb":{"@id":"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#primaryimage","url":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/01\/Roche-Logo.jpg","contentUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/01\/Roche-Logo.jpg","width":480,"height":283,"caption":"Atrofia"},{"@type":"BreadcrumbList","@id":"https:\/\/jurmed.ro\/medici\/femeile-din-romania-care-sufera-de-o-forma-agresiva-de-cancer-de-san-au-de-acum-un-nou-tratament\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/jurmed.ro\/medici\/"},{"@type":"ListItem","position":2,"name":"Femeile din Romania care sufera de o forma agresiva de cancer de san au de acum un nou tratament"}]},{"@type":"WebSite","@id":"https:\/\/jurmed.ro\/medici\/#website","url":"https:\/\/jurmed.ro\/medici\/","name":"Jurmed - Medici","description":"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jurmed.ro\/medici\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Person","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/d32bd0fe3243bb12082045e5e5635d2d","name":"costelv","image":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/562bbd538aef9094eff6466c34ed9504fe82c1cb144e421d853e80c3b3d5a9f8?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/562bbd538aef9094eff6466c34ed9504fe82c1cb144e421d853e80c3b3d5a9f8?s=96&r=g","caption":"costelv"},"url":"https:\/\/jurmed.ro\/medici\/author\/costelvoicu\/"}]}},"_links":{"self":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/13395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/comments?post=13395"}],"version-history":[{"count":2,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/13395\/revisions"}],"predecessor-version":[{"id":13397,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/13395\/revisions\/13397"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/media\/7607"}],"wp:attachment":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/media?parent=13395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/categories?post=13395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/tags?post=13395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}